#CAP1002 - Twitter Hashtag

almost 2 years ago

Capricor announces Pre-BLA meeting with FDA for Deramiocel (CAP-1002) for the treatment of Duchenne Muscular Dystrophy #CAPR #DMD #CAP1002 >>> Click to view the press release>>>https://t.co/xrumYqu5ox

Capricor's tweet photo. Capricor announces Pre-BLA meeting with FDA for Deramiocel (CAP-1002) for the treatment of Duchenne Muscular Dystrophy #CAPR #DMD #CAP1002 >>> Click to view the press release>>>https://t.co/xrumYqu5ox https://t.co/I3vYTRsjkU

1

19

4

1

946

Capricor Therapeutics

@Capricor

about 2 years ago

Capricor announces positive Type-B meeting with FDA for CAP-1002 program for DMD. FDA grants Pre-BLA meeting request and rolling BLA submission after data review. #DMD #CAP1002 #CAPR <<<Click here to view the announcement>>>https://t.co/lARqvdf3FO

Capricor's tweet photo. Capricor announces positive Type-B meeting with FDA for CAP-1002 program for DMD. FDA grants Pre-BLA meeting request and rolling BLA submission after data review. #DMD #CAP1002 #CAPR <<<Click here to view the announcement>>>https://t.co/lARqvdf3FO https://t.co/sIyfL2Pmd6

1

12

1

0

511

Capricor Therapeutics

@Capricor

about 2 years ago

Capricor is excited to be presenting at this year's CureDuchenne 2024 FUTURES Conference happening this weekend in Orlando. #CAPR #DMD #CAP1002 #CureDuchenne #FUTURES2024 >>>Click here to view the agenda>>> https://t.co/zMEY3wu3zt

Capricor's tweet photo. Capricor is excited to be presenting at this year's CureDuchenne 2024 FUTURES Conference happening this weekend in Orlando. #CAPR #DMD #CAP1002 #CureDuchenne #FUTURES2024 >>>Click here to view the agenda>>> https://t.co/zMEY3wu3zt https://t.co/yadWyFm7io

0

3

0

384

Capricor Therapeutics

@Capricor

about 2 years ago

Capricor is scheduled to present at several upcoming scientific and medical conferences this month! $Cape #DMD #CAP1002 #exosomes >>>Click the link to read press release and see details for the upcoming presentations>>https://t.co/wDmAdNf1mi

Capricor's tweet photo. Capricor is scheduled to present at several upcoming scientific and medical conferences this month! $Cape #DMD #CAP1002 #exosomes >>>Click the link to read press release and see details for the upcoming presentations>>https://t.co/wDmAdNf1mi https://t.co/m8aqC2qhS1

0

4

1

0

208

Capricor Therapeutics

@Capricor

about 2 years ago

Don’t forget to join Capricor’s webcast being held today at 8:30 a.m. ET for an update on our CAP-1002 program for DMD. #CAPR #CAP1002 #DMD >>> Click the link to access the webcast>>> https://t.co/kq5rxSzN1p

Capricor's tweet photo. Don’t forget to join Capricor’s webcast being held today at 8:30 a.m. ET for an update on our CAP-1002 program for DMD. #CAPR #CAP1002 #DMD >>> Click the link to access the webcast>>> https://t.co/kq5rxSzN1p https://t.co/mrbVPnwo9Q

0

4

0

225

Capricor Therapeutics

@Capricor

about 2 years ago

Capricor announces positive Type-B meeting with FDA for CAP-1002 program for DMD. We will host a webcast to discuss this meeting and the latest program updates on Monday, April 29 at 8:30 am ET. #CAPR #CAP1002 #DMD > Click here to view the press release > https://t.co/cNGDQ7zL34

Capricor's tweet photo. Capricor announces positive Type-B meeting with FDA for CAP-1002 program for DMD. We will host a webcast to discuss this meeting and the latest program updates on Monday, April 29 at 8:30 am ET. #CAPR #CAP1002 #DMD > Click here to view the press release > https://t.co/cNGDQ7zL34 https://t.co/gVNLVPMJNS

0

5

2

0

290

Capricor Therapeutics

@Capricor

over 2 years ago

On this Rare Disease Day, we recognize the patients and families afflicted with rare diseases. DMD is considered one of the most common, affecting 1 in 3,500 male births. Learn more about our commitment to those suffering with DMD. >>https://t.co/4inWqFn8F0>> #CAPR #CAP1002 #DMD

Capricor's tweet photo. On this Rare Disease Day, we recognize the patients and families afflicted with rare diseases. DMD is considered one of the most common, affecting 1 in 3,500 male births. Learn more about our commitment to those suffering with DMD. >>https://t.co/4inWqFn8F0>> #CAPR #CAP1002 #DMD https://t.co/ltUy7dvNew

0

3

1

0

226

Capricor Therapeutics

@Capricor

over 2 years ago

Capricor announces upcoming Type-B meeting with the FDA to discuss commercial manufacturing planning with an aim to expedite BLA pathway for CAP-1002 in Duchenne Muscular Dystrophy #CAPR #DMD #CAP1002 #FDA >>>Click the link to read the full press release>>>https://t.co/McBd3rZlxw

Capricor's tweet photo. Capricor announces upcoming Type-B meeting with the FDA to discuss commercial manufacturing planning with an aim to expedite BLA pathway for CAP-1002 in Duchenne Muscular Dystrophy #CAPR #DMD #CAP1002 #FDA >>>Click the link to read the full press release>>>https://t.co/McBd3rZlxw https://t.co/cB22QUmWF6

1

12

3

0

610

Capricor Therapeutics

@Capricor

over 2 years ago

Capricor announces manufacturing scale-up of CAP-1002 production at our new San Diego facility #CAPR #CAP1002 #DMD >>>Click the link to read the full press release>>> https://t.co/RRujuIot2b

Capricor's tweet photo. Capricor announces manufacturing scale-up of CAP-1002 production at our new San Diego facility #CAPR #CAP1002 #DMD >>>Click the link to read the full press release>>> https://t.co/RRujuIot2b https://t.co/G1zNm69oCN

0

4

3

0

319

Capricor Therapeutics

@Capricor

over 2 years ago

Capricor is excited to be attending the 42ndAnnual @jpmorgan Healthcare Conference this week in San Francisco! We are looking forward to connecting with our #biotech industry partners and investors on the latest developments for our #CAP1002 and exosome platforms. #CAPR #JPM24

Capricor's tweet photo. Capricor is excited to be attending the 42ndAnnual @jpmorgan Healthcare Conference this week in San Francisco! We are looking forward to connecting with our #biotech industry partners and investors on the latest developments for our #CAP1002 and exosome platforms.
#CAPR #JPM24 https://t.co/bO8RxFLJCS

2

12

1

1K

Capricor Therapeutics

@Capricor

over 2 years ago

In case you missed it! We partnered with @PPMD for a #DMD webinar held last week. We summarized our recent regulatory updates for our Phase 3, HOPE-3 study of our lead product, CAP-1002. Follow this link to watch the presentation! https://t.co/m0GHDgyCCQ #CAP1002 #PPMD $CAPR #DMD

Capricor's tweet photo. In case you missed it! We partnered with @PPMD for a #DMD webinar held last week. We summarized our recent regulatory updates for our Phase 3, HOPE-3 study of our lead product, CAP-1002. Follow this link to watch the presentation! https://t.co/m0GHDgyCCQ
#CAP1002 #PPMD $CAPR #DMD https://t.co/bihcFYdOdB

0

2

0

372

Capricor Therapeutics

@Capricor

over 2 years ago

You will not want to miss the Capricor and @PPMD webinar being held today at 1:00 p.m. ET. Please click here to register >> https://t.co/WZzX8jCmSV $CAPR #PPMD #CAP1002 #DMD

Capricor's tweet photo. You will not want to miss the Capricor and @PPMD webinar being held today at 1:00 p.m. ET. Please click here to register >> https://t.co/WZzX8jCmSV
$CAPR #PPMD #CAP1002 #DMD https://t.co/22dMSRHVma

0

3

0

1

401

Capricor Therapeutics

@Capricor

over 2 years ago

Capricor is partnering with @PPMD for a webinar on Wednesday, Oct 25th at 1:00 p.m. ET. We will provide the most up-to-date regulatory developments for our ongoing HOPE-3 Phase 3 study of our lead product, CAP-1002. Register >>> https://t.co/WZzX8jCUIt #PPMD $CAPR #CAP1002 #DMD

Capricor's tweet photo. Capricor is partnering with @PPMD for a webinar on Wednesday, Oct 25th at 1:00 p.m. ET. We will provide the most up-to-date regulatory developments for our ongoing HOPE-3 Phase 3 study of our lead product, CAP-1002. Register >>> https://t.co/WZzX8jCUIt
#PPMD $CAPR #CAP1002 #DMD https://t.co/9XWpV9psiq

0

4

1

0

415

Capricor Therapeutics

@Capricor

over 2 years ago

We are excited to announce the outcome from our positive Type-B Meeting with FDA to discuss our pathway to BLA for CAP-1002 for the treatment of DMD. Learn more about this key milestone here >>> https://t.co/E5oW2y8Nxe $CAPR #DMD #CAP1002

Capricor's tweet photo. We are excited to announce the outcome from our positive Type-B Meeting with FDA to discuss our pathway to BLA for CAP-1002 for the treatment of DMD.
Learn more about this key milestone here >>> https://t.co/E5oW2y8Nxe
$CAPR #DMD #CAP1002 https://t.co/FETdGXT4x4

2

5

1

0

747

Capricor Therapeutics

@Capricor

almost 3 years ago

Capricor welcomes Mike Kelliher to our Board of Directors. Mike’s biopharmaceutical expertise and strong track record of promoting success across multiple facets encourages us towards our goals. Click here to read the press release! https://t.co/mvrvGKeTFl $CAPR #CAP1002 #biotech

Capricor's tweet photo. Capricor welcomes Mike Kelliher to our Board of Directors. Mike’s biopharmaceutical expertise and strong track record of promoting success across multiple facets encourages us towards our goals. Click here to read the press release! https://t.co/mvrvGKeTFl
$CAPR #CAP1002 #biotech https://t.co/pR4tNCIj8H

0

6

0

375

Capricor Therapeutics

@Capricor

almost 3 years ago

Capricor wishes everyone and all our employees a Happy Labor Day! $CAPR #CAP1002 #exosomes #laborday23

0

5

0

421

Capricor Therapeutics

@Capricor

almost 3 years ago

Did you miss Capricor’s second quarter corporate update call yesterday? You can still watch a recap of the discussion by viewing the webcast. Please click here to get the latest update on Capricor ---https://t.co/Z6U1Orbbkr #biotech $CAPR #CAP1002 #DMD

Capricor's tweet photo. Did you miss Capricor’s second quarter corporate update call yesterday? You can still watch a recap of the discussion by viewing the webcast. Please click here to get the latest update on Capricor ---https://t.co/Z6U1Orbbkr
#biotech $CAPR #CAP1002 #DMD https://t.co/yNV9QH1yTi

0

5

0

530

Capricor Therapeutics

@Capricor

almost 3 years ago

Capricor Reports Second Quarter 2023 Financial Results and Provides Corporate Update. To read the press release, click here: https://t.co/dwl2zjzuiq $CAPR #earnings #DMD #exosomes #CAP1002

Capricor's tweet photo. Capricor Reports Second Quarter 2023 Financial Results and Provides Corporate Update. To read the press release, click here: https://t.co/dwl2zjzuiq
$CAPR #earnings #DMD #exosomes #CAP1002 https://t.co/tcHT9kHcwS

0

2

0

469

Capricor Therapeutics

@Capricor

almost 3 years ago

Our CEO, Linda Marban sharing the most recent data from our HOPE-2 open label extension study at this year’s #PPMDConference. To view the webcast, please register at >>>>> https://t.co/JZlhyn8VtQ. #PPMDconference #DMD #CAP1002 $CAPR

Capricor's tweet photo. Our CEO, Linda Marban sharing the most recent data from our HOPE-2 open label extension study at this year’s #PPMDConference.
To view the webcast, please register at >>>>> https://t.co/JZlhyn8VtQ.
#PPMDconference #DMD #CAP1002 $CAPR https://t.co/PpLFHSe4lj

0

5

0

487

Capricor Therapeutics

@Capricor

almost 3 years ago

Capricor announces positive 24-month results from ongoing HOPE-2 open label extension study of CAP-1002 in Duchenne muscular dystrophy. Click here to view the press release https://t.co/pvvFx1JAS2 #PPMDconference #DMD #CAP1002 $CAPR

Capricor's tweet photo. Capricor announces positive 24-month results from ongoing HOPE-2 open label extension study of CAP-1002 in Duchenne muscular dystrophy. Click here to view the press release https://t.co/pvvFx1JAS2
#PPMDconference #DMD #CAP1002 $CAPR https://t.co/oBF5cWEvyH

1

12

3

0

784

Top Tweets for #CAP1002

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users